With IV formulation resetting the patent clock and the size of the potential opportunity in front of Zantrene, a high percentage royalty partnership with BP could be more advantageous than the original buy out plans we all had a year ago.
Looking forward to seeing which way it all goes down.
General Comments / Chat, page-6196
-
- There are more pages in this discussion • 5,285 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
0.010(0.60%) |
Mkt cap ! $284.5M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.65 | $70.16K | 42.06K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5386 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 7597 | 2 |
View Market Depth
| Last trade - 15.55pm 13/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |